Novoeight (turcotococog alfa) Antihemophilic Factor (Recombinant) Briefing Materials
For the March 7, 2017 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
- Novoeight Safety and Utilization Review
- Novoeight Statistical Review
- Novoeight Clinical Review
- Novoeight Labeling